Upgrade Your Browser
We no longer support this version of your browser.
We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.
Return to the course you were viewing
Just Launched! RxAdvanced hospital competency training for pharmacists and PTU Elite: Immunizations pharmacy technician training program. Get a quote.
a hormone secreted by the pancreas. It
helps the body use glucose (sugar) as an energy source by acting like a “key”
that allows glucose to enter the body’s tissues. People with diabetes either don’t produce insulin (type 1) or don’t use available insulin properly
or make enough insulin (type 2). Without
the right amounts or proper functioning of insulin, glucose builds up in the
blood and other organs and causes tissue damage or death. Although type 2 diabetes can often be managed
with oral medications, many type 2 patients and all type 1 patients will
require injections of insulin.
are many types of insulin available to meet patients’ individual needs, such as
the traditional versions with 100 units/mL of insulin, called U-100. There are also some “concentrated” versions
that have 200 units/mL (Humalog U-200,
Tresiba U-200), 300 units/mL (Toujeo SoloStar and Toujeo Max SoloStar [U.S.]), or 500 units/mL (Humulin R 500 units/mL [U.S.], Entuzity
are also other injectable drugs used to treat diabetes besides insulin. They include exenatide (Byetta), exenatide extended-release (Bydureon, Bydureon BCise
[U.S.]), liraglutide (Victoza), lixisenatide
(Adlyxin [U.S.], Adlyxine [Canada]), dulaglutide (Trulicity), and semaglutide (Ozempic). These “GLP-1 agonist” meds help increase the
body’s own natural secretion of insulin.
Pramlintide (Symlin [U.S.]) is
another injectable diabetes med. It
helps reduce blood glucose in a different way than increasing insulin levels.
Insulins are considered high-risk
medications because they are frequently implicated in serious medication
high-risk meds, even small errors can be deadly. Examples of insulin errors include confusion
between insulin products, concentrations, or dosage forms, and the use of dangerous abbreviations such as “u” for units on Rxs for insulin.
“U” can be mistaken for a number “4” or a zero, resulting in an
overdose. Be vigilant when dispensing
insulin and other injectable diabetes meds, and refer Rxs that seem inappropriate
to your pharmacist. You can learn more
about safety considerations with high-risk meds by taking our CE, Improving Safety with High-Alert Medications
in the Community.
Mrs. Mackey, a 55-year-old female patient, presents a prescription for one vial of insulin to be used as directed. You notice that the abbreviation “ud,”
meaning “use as directed,” could easily be mistaken for “4 days” or “40.” You also see a letter that could either be an
“N” or an “R” after the drug name. This
could lead to incorrect interpretation of the prescription as being written for
Humulin N instead of Humulin R, or vice versa. There’s also no concentration specified on
the order, so it’s unclear if the patient should get Humulin R U-100 or Humulin R U-500. You check with your pharmacist, who is able
to clarify with the prescriber that the order is for Humulin R U-100.
What should be done
when inputting an insulin or other injectable diabetes med Rx?
Choose the correct product. Some brands of insulin, such as Lantus and Humalog U-100, come in both a vial and as a pen. Pay attention to different formulations of
the same med, and be sure to select the right one. Watch out for mix-ups between look-alike/sound-alike
drug names too, such as Byetta and Bydureon or Bydureon and Bydureon BCise. Byetta is dosed twice daily. Bydureon
and Bydureon BCise are dosed once per week. Although Bydureon and Bydureon BCise
both contain extended-release exenatide and are given weekly, they have
different devices and can’t be automatically substituted. Humulin
and Humalog mix-ups are common. Levemir
and Lantus can also be
confused. Lantus has even been confused with Humalog even though they look and sound different. Confusion can also arise with diabetes meds
that begin with the letter “T,” including Tradjenta
(U.S.), Trajenta (Canada), Trulicity, Toujeo SoloStar, Toujeo Max SoloStar
(U.S.), and Tresiba. And orders written for “insulin glargine” could
be for U-100 Basaglar, Lantus, or Lantus SoloStar or U-300 Toujeo
SoloStar or Toujeo Max SoloStar. While
orders written for “insulin aspart” could be for Novolog (U.S.), NovoRapid (Canada),
or Fiasp. And orders for “insulin lispro” could be for Admelog,
Humalog U-100, or Humalog U-200. Don’t automatically switch any of these
products, they’re not equivalent.
Double-check that you choose the correct
concentration. For example, Tresiba comes in U-100 and U-200 versions.
R comes in U-100 and U-500 versions.
Dispensing the wrong concentration could lead to the patient having
dangerously high or dangerously low blood sugar. If you get an Rx without a concentration,
clarify this with a pharmacist so the correct product will be dispensed.
Watch for duplicate therapy. Many
patients will use more than one type of insulin, such as a shorter-acting insulin
(regular, lispro, aspart, etc) with meals and a longer-acting insulin (glargine,
detemir, degludec, etc) once a day. However,
duplicate therapy issues come into play when the patient has prescriptions for two
or more of the same type of insulin. For
example, if a patient has prescriptions for both Lantus (insulin
glargine) and Levemir (insulin detemir), you should bring this to the
attention of the pharmacist. Also, there
are some products that are combinations of a GLP-1 agonist and long-acting
insulin (e.g., Soliqua [lixisenatide/insulin glargine], Xultophy [liraglutide/insulin
degludec]). Be sure that patients taking
these meds are no longer getting prescriptions filled for the individual components.
Enter dosing instructions completely. Insulin prescriptions may have especially
complex instructions. Be sure to check notes
on e-Rxs for extra instructions from the prescriber. Pay special attention when entering dosing
instructions for these Rxs into the computer.
Make sure the Rx label reads exactly as it is written on the
prescription. Additional label space may
be required for detailed instructions.
aware that a prescriber might write the Rx instructions for insulin as “use as
directed,” allowing changes to be communicated directly to the patient. (Insurers frown upon using “use as directed,”
and the pharmacist will often need to clarify instructions with the
prescriber.) Patients may be instructed
by the prescriber on how to vary the dose of their short-acting (e.g., Humulin R) or rapid-acting (e.g., Humalog) insulin depending on what they eat
at each meal. You may also see Rxs written
for “SS” or “sliding scale” insulin.
This is more common in the hospital or nursing home setting. A sliding scale means the dose of insulin
varies depending on the patient’s blood sugar.
Enter an accurate quantity to be dispensed. One vial of insulin typically contains 10 mL
of insulin. Prescription quantities for
liquids are usually entered as the number of mL instead of the number of vials
or packages dispensed for reimbursement purposes. In this case, entering the quantity as “1”
for the number of insulin vials dispensed may cause inadequate reimbursement. This may be communicated as “1 mL,” instead of
the full 10 mL contained in one vial.
pens that come in multipacks, such as Victoza,
make sure to enter the total number of mL in the whole box or carton instead of
the number of pens or the number of mL in one pen. For example, a five-pack of insulin pens that
contain 3 mL of drug each will require entering a dispense quantity of 15 mL.
Enter an accurate days’ supply. When specific dosing instructions are included,
a days’ supply value can be calculated.
Divide the total number of units per vial, pen, or box by the total units
If a patient uses 100 units of insulin per day, how long will one 10 mL
vial of insulin 100 units/mL last?
units/mL x 10 mL/vial = 1,000 units/vial; 1,000 units/vial x 1 day/100 units =
specific dosing instructions are NOT provided on the prescription, the
pharmacist may need to clarify this information with the prescriber’s
office. You can also consider asking the
patient how they have been advised to take the medication to help you determine
how long the medication should last. An
incorrect days’ supply entered into the computer can cause future third-party
problems. Insurance companies will often
reject a claim with a “refill too soon” message if a claim is transmitted before
the previous prescription’s days’ supply has passed. For example, if a prescription is entered for
a 30-day supply, the insurance will not pay for a refill of that medication if
the patient runs out in just 14 days.
Also, billing incorrectly can lead to audits or chargebacks.
Get the pharmacist involved if insulin is
too expensive. They may be able to get
the patient switched to a more affordable insulin product. For example, regular insulin, NPH, or 70/30
insulin may be less expensive than other types of insulin and can lower blood sugar
levels similar to other types of insulin. Generic versions of insulin may also help
patients save money. For instance, authorized
generics for Humalog U-100 (insulin lispro),
NovoLog (insulin aspart), and NovoLog Mix 70/30 (insulin aspart
protamine/insulin aspart) were recently brought to market in the U.S. These authorized generics are less expensive
than the brand and lower blood glucose the same amount as the brand. Also pay attention to late refills for insulin
prescriptions; this could be a sign that patients are rationing to save money.
Since Mrs. Mackey’s prescription indicated
to “use as directed,” the pharmacist calls the prescriber’s office to get more
specific instructions to help prevent an insurance audit. The detailed instructions are to use 15 units
of insulin with each meal. You enter the
quantity dispensed as 10 mL and calculate that if Mrs. Mackey eats three meals a
day, she is expected to use about 45 units each day. You enter a days’ supply of 22 days (1,000
units/vial x 1 day/45 units = 22 days/vial).
What should be done
when selecting insulin or other injectable diabetes meds from the fridge?
are several different types of insulins available. Human insulin analogs are human insulin that
has been modified to make the insulin act more quickly for use around mealtimes
(e.g., NovoLog [U.S.], NovoRapid [Canada], Humalog, Apidra) or last
longer (e.g., Basaglar, Levemir, Lantus). Mixtures of short-
and longer-acting insulins are also available to reduce the number of
injections for patients requiring both types.
For example, Humulin 70/30 is
70% NPH (an intermediate-acting insulin) and 30% regular insulin (a short-acting
insulin). It’s a good idea to use
separate bins or shelf alerts to distinguish among products that look similar.
mentioned, insulin most commonly comes in a concentration of 100 units per mL,
or U-100. Vials contain 10 mL, or 1,000
units (100 units/mL x 10 mL/vial = 1,000 units/vial). The 500 unit per mL version of Humulin R is available by prescription
in the U.S. for patients requiring large doses.
In Canada, U-500 insulin (Entuzity
Kwikpen) is also available by prescription. If this very concentrated insulin, or other concentrated
insulins, such as Toujeo or Tresiba U-200, are available in your
pharmacy, consider keeping them in a special place in the fridge to avoid mix-ups.
insulins, such as Humalog, Lantus, and NovoLog (U.S.), are available as pre-filled pens, or as cartridges
to be used with a reusable pen. The
other injectable diabetes meds (e.g., exenatide, liraglutide, pramlintide) also
come as pre-filled pens. With pens,
patients just “dial up” the dose they need and inject it. For more details about all the insulins and
the other injectable meds for diabetes, including formulations, storage,
administration devices, cost, etc, see our charts, Comparison of Insulins (U.S.
subscribers) and Comparison
of GLP-1 Agonists (U.S. subscribers; Canadian
you see that a patient is switching from one pen device to another, let the
pharmacist know so that he or she can make sure the patient knows the proper
technique for using the new pen.
To fill Mrs. Mackey’s Rx, you choose Humulin
R, which is regular human insulin. When you remove the insulin from the refrigerator,
you take care not to confuse Humulin R
with Humulin N (an intermediate-acting
insulin), Humalog (a rapid-acting
analog), or a Humulin or Humalog mixture.
You also make sure you have U-100 and not the higher strength U-500.
What should be
considered when labeling insulin or other injectable diabetes meds?
labeling insulin and other injectable diabetes meds, take care not to cover the
name of the product, storage information, expiration date, and NDC code (DIN in
Canada) that may be printed on the box.
If more than one vial or package of pens is needed to fill a
prescription, print duplicate labels.
A label with a “use by” date is helpful for the patient,
since these meds are usually good for around a month (often less than this for
pens) once they are dispensed and stored at room temperature. For patients who get a supply of multiple
vials or pens to last for a few months, a “refrigerate” label is helpful to
remind them to keep the med in the fridge until they start using it. Our charts, Comparison of Insulins and Comparison
of GLP-1 Agonists, also have information on room temperature stabilities.
It’s important to note that most insulins and other
injectable meds that come in pens should not be placed back in the refrigerator
once they are in use. At this point, they should usually only be
stored at room temperature. Storing them
in the fridge can actually cause some pens to malfunction and leak.
In the hospital setting, keep in mind the mantra “one pen,
one patient.” It is important to label
insulin pens for individual patients.
Make sure a patient-specific label is attached to the pen itself and not
just to the cap or the bag it is delivered in to help prevent mix-ups between
patients. Even if the needle on a pen is
changed, there is still a risk for cross contamination between patients. Nurses should never use one patient’s pen to
administer insulin to another patient.
Get our chart, Tips to Improve Insulin Safety, for more strategies to help prevent errors with insulin.
Although Humulin R requires refrigeration while stored in the pharmacy, it can be kept at
room temperature for up to 28 days once in use.
You place an auxiliary label indicating this on Mrs. Mackey’s prescription. When the pharmacist counsels Mrs. Mackey, he
also gives her storage information.
considerations apply to insulin and other injectable diabetes meds?
Once the Rx is ready, it should be stored in
the refrigerator until it’s picked up.
Workflow for storage and retrieval of refrigerated Rxs such as insulin
varies among pharmacies. Many pharmacies
place an empty bag, label, and receipt in an alphabetized bin near the cash
register, but store medication in a “patient pickup” bin in the refrigerator. With this method, Rx bags are located in the
normal pharmacy storage area, while insulin is stored in the fridge. Make sure to use a “refrigerate” sticker or
another reminder on the receipt and bag with this method, to ensure that the
insulin is retrieved from the refrigerator when the patient pays for the Rx. Other pharmacies may have a separate storage
area in the refrigerator for labeled and bagged prescriptions that are ready to
be picked up. Get our technician tutorial, Keep
It Cool: Storing Meds in the Fridge or
Freezer, for more information on proper storage
of refrigerated meds.
What should be
considered when dispensing insulin syringes and pen needles?
insulin syringes and pen needles can be purchased without a prescription however, a prescription is required for third-party coverage. In some locations, depending on state law or
store policy, insulin syringes require a prescription, or can only be dispensed
along with insulin. Be sure to enter the
insulin prescription in the computer before prescriptions for syringes or other
diabetes supplies. Some third-party
payers reject coverage for diabetes supplies until the insulin prescription has
been entered because they need to detect an “active” insulin prescription to
justify the diabetes supplies.
syringes are marked in units, not in mL like most other syringes. Most insulin syringes are designed to be used
with insulin vials containing insulin at a concentration of 100 units per
mL. Insulin syringes differ in the total
amount of insulin they can hold (e.g., 100 units [1 mL], 50 units [0.5 mL], 30
units [0.3 mL]). Insulin syringes come
with a needle attached. The “gauge” of the
needle tells you how fine, or thin, the needle is. The larger the gauge, the thinner the needle. For example, 31-gauge needles are thinner
than 28-gauge needles. Thinner needles
may be more comfortable for the patient, they also get bent more easily. Needles also differ in regard to the
length. Some common needle lengths are ½
inch (12.7 mm) and 5/16 inch (8 mm).
Some patients prefer shorter needles for comfort. But shorter needles may not be long enough
for overweight patients. Refer patients
who complain about injection pain to the pharmacist. They may need a shorter and/or thinner
in mind that an insulin syringe specifically for use with U-500 insulin is now
available in the U.S. These syringes
will help patients who use Humulin R
U-500 vials avoid dangerous dosing errors that can happen when they draw their
doses up with syringes meant to measure out U-100 insulin. These U-500 syringes require a prescription,
and should only be used with U-500 insulin.
It’s important not to mix them up with U-100 syringes. The U-500 syringes come in a green box, with
a green cap and “U-500” on the barrel, to match up with newer U-500 insulin
labeling and to help prevent errors.
insulin syringes, insulin pens and other injectable diabetes meds require pen needles. When dispensing an insulin pen, be sure to
choose the correct pen needle for the specific pen. Pen needles come in different sizes, similar
to needles on insulin syringes. If you are
unsure of which brand name or needle type a patient’s pen requires, check with
the pharmacist. You may also be able to
find this info in the “How Supplied” section of the prescribing information in
the U.S., or the “Dosage Forms, Composition and Packaging” section of the
product monograph in Canada. Process the
pens and pen needles as two separate prescriptions. Even though pen needles are OTC, most
insurances will cover them as long as the patient has a prescription for
them. Patients should be discouraged
from reusing their pen needles or leaving them on their pen. Reuse can increase the risk of injection pain
and infection. Leaving them on can cause
air bubbles, leaks, contamination, or clogging of the pen. Watch for patients who switch pen needle
brands. The way pen needles are used may
differ between products.
Mrs. Mackey returns the next day with the following
prescription, which she forgot to bring in before: Lantus 15 units at bedtime, dispense a one-month supply, with three refills. Lantus
is insulin glargine, a long-acting insulin.
You know that it’s normal for a patient to use more than one type of
insulin at a time.
How do you
calculate how much insulin to dispense?
How is this entered into the computer?
will need 15 units per day for 30 days. You
calculate that she will need 450 units for a 30-day supply (15 units/day x 30
days = 450 units). You know that each 10
mL insulin vial contains 1,000 units of insulin (100 units/mL x 10 mL/vial = 1,000
units/vial), so you dispense one vial of Lantus for a one-month supply. However, since Lantus vials must be discarded after 28 days once they are in use, you enter
a 28-day supply into the computer.
insulin storage and stability in mind when entering days’ supply for insulin Rxs. In the above example, Mrs. Mackey will only use
about one-half of one Lantus vial in
30 days at her current dose of 15 units daily.
When entering the days’ supply amount for this Rx, it would seem logical
that one vial is enough insulin for two months.
However, any in-use Lantus
vials should be discarded after 28 days.
As such, this Rx should be entered into the computer as being for one 10
mL vial and a 28-day supply.
be alert for patients requiring multiple vials for a one-month supply of insulin. For example, if this Rx had been for 40 units
at bedtime, two vials (20 mL) would be dispensed (40 units/day x 30 days = 1,200
units, requiring two vials). Also
consider the patient’s third-party coverage.
In some cases, the patient pays less if they get a 90-day supply at one
time. If Mrs. Mackey’s Rx was written
for a 90-day supply, that would be three vials of Lantus, taking the
28-day expiration for an “in use” vial into account. The pharmacist would tell Mrs. Mackey to keep
the unused vials in the refrigerator until she needs them.
pens can be tricky. It’s important to be
aware that in the U.S., the FDA-approved labeling for insulin pens now
explicitly states to dispense in the original sealed carton. This helps ensure patients get the “Patient
Information” and “Instructions for Use” which come with each box. In the past, pharmacies may have broken a box
in order to dispense just enough insulin to meet payer quantity limits. With this recent change to the FDA-approved
labeling, now pharmacies are at risk of audit if they DON’T dispense a full
box. This can pose a challenge depending
on how much insulin a patient is using.
For example, if the Rx above was for Lantus
SoloStar, authorization from Mrs. Mackey’s prescriber will be needed to change
the Rx quantity to a full box of the Lantus
SoloStar pens. The full box would be
entered into the computer with a quantity of 15 mL (5 pens x 3 mL), and a days’
supply of 100 days (300 units/pen x 1 day/15 units = 20 days/pen; 5 pens x 20
days/pen = 100 days). Many insurance
companies have days’ supply limits, and in this example, 100 days will likely exceed
most insurance company limits. Always
follow your company’s policy on how to handle these situations, and consider some
general best practices. For example, dispense
a full box and always first bill an accurate days’ supply based on the
prescribed quantity. If plan limits are
exceeded, call the payer’s help desk to request an override. If no override is available, clearly document
the payer’s guidance on the Rx hard copy and in the computer. For example, you’ll want to make note of insurance
limits, actual days’ supply, and whether to adjust days’ supply. Talk to your pharmacist about including the
actual days’ supply in the Rx sig, such as, “1 box should last 100 days.” Put a flag in the patient profile to indicate
that this Rx shouldn’t be refilled earlier than the date which reflects the
actual days’ supply. Be sure not to
enroll these Rxs in automatic refill programs, as this could be considered
fraud due to overbilling.
Can insulin be
dispensed without a prescription?
the U.S., some insulins are OTC (e.g., Humulin
R U-100, etc), while other insulins, such as Lantus, require an Rx. For third-party coverage, an Rx is necessary,
even for OTC insulins. In Canada, injectable
insulins are nonprescription/Schedule II (i.e., only available with pharmacist
Project Leader in preparation of this technician
tutorial (350780): Flora Harp, PharmD/Associate
Editor, last modified March 2020.
Cite this document as follows: Technician Tutorial, Dispensing Insulin and Other Injectable Diabetes
Meds. Pharmacist’s Letter/Pharmacy
Technician’s Letter. July 2019.
for a dispensing insulin “cheat sheet”—
Sheet” for Dispensing Insulin and Other Injectable Diabetes Meds
What are the different injectable diabetes meds that are available and
how do they work?
The common types of injectable
diabetes meds include various insulin products (Lantus, Humalog, Novolin, etc) and GLP-1 agonists (exenatide
[Byetta], exenatide extended-release [Bydureon, Bydureon BCise (U.S.)], liraglutide [Victoza], lixisenatide [Adlyxin
(U.S.), Adlyxine (Canada)], dulaglutide [Trulicity],
and semaglutide [Ozempic]). People with diabetes either don’t produce
insulin (type 1) or don’t use available insulin properly (type 2). Insulin is needed to help the body use
glucose as an energy source and to prevent glucose buildup in the blood and
organs. GLP-1 agonists help increase the
body’s own natural secretion of insulin.
What should I be sure to do when dispensing insulin or other diabetes
What should be considered when dispensing insulin syringes
and pen needles?
Hospital Pharmacist's Letter includes:
Already a subscriber? Log in
Not sold to individuals